Formulating and Implementing Pharmaceutical Pricing Policies

Professor Zaheer Babar is a Professor of Clinical Pharmacy and Practice at the College ofPharmacy, Qatar University, and serves as a Visiting Professor in the Department of Pharmacyat the University of Huddersfield in the United Kingdom. He has extensively published researchon medicine pricing and access to medications, gaining international recognition for hiscontributions to pharmaceutical policy. Professor Babar has collaborated with organizationssuch as the United Nations Development Programme (UNDP), Health Action International,Management Sciences for Health (MSH), the International Union Against Tuberculosis andLung Disease, and the World Bank to develop medicine pricing policies for various countries.His edited work include “Economic Evaluation of Pharmacy Services,” “Pharmaceutical Pricesin the 21st Century,” “Pharmaceutical Policies in Countries with Developing HealthcareSystems,” “Global Pharmaceutical Policy,” “Access to High-Cost Medicines,” “PharmacyPractice Research Methods,” “Pharmacy Practice Research Case Studies,” “Encyclopedia ofPharmacy Practice and Clinical Pharmacy.” And “Encyclopedia of Evidence in PharmaceuticalPublic Health and Health Services Research in Pharmacy.”

• 1. Pharmaceutical pricing policies: Introduction, key concepts and evidence synthesis2. Analysis of anti-retroviral medicines prices: A review of literature3. Evidence on pharmaceutical pricing policies in Europe4. Pharmaceutical pricing policies in Italy5. Pharmaceutical pricing policies in Indonesia6. Canada’s medicine pricing policies: implementation strategies and models7. Pharmaceutical pricing policies in Thailand8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis9. Strategies for medicine pricing in Southeast Asia10. Pharmaceutical pricing policies in Syria11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement13. Pharmaceutical pricing policies in Spain14. Pharmaceutical pricing strategies in the US15. Money matters – How financing for medicines R&D affects medicines, and what to do about it16. The role of Civil Society Organizations ensuring price transparency17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil18. Pharmaceutical pricing policies in Greece